（英文原文）PrognosticvalueofCHA2DS2-VAScscoreinpatientswith‘non-valvularatrialfibrillation’andvalvularheartdisease:theLoireValleyAtrialFibrillationProject
AimsTheCHA2DS2-VAScscoreisaclinicalriskstratificationtoolwhichestimatestheriskofstrokeandthromboembolisminnon-valvularatrialfibrillation(AF).Weaimedtoestablishthevalueofthisscoreforriskevaluationinpatientswithnon-valvularAFandvalvularheartdisease.
MethodsandresultsAmongpatientswithnon-valvularAF(ESCguidelinesdefinition),patientswerecategorizedintoGroup1(novalvedisease,n=;85%)andGroup2(valvediseasewithneitherrheumaticmitralstenosisnorvalveprothesis,n=;15%).Afterfollow-upof±days,stroke/thromboembolic(TE)eventswererecorded.Group2wassignificantlyolder,hadahigherCHA2DS2-VAScscoreandhadahigherriskofthromboembolicevents[hazardratio(HR)1.39;95%CI1.14–1.69,P=0.]哈尔滨白癜风专科医院哪家医院能治愈白癜风
